Targovax reports 100% one-year survival in... Norwegian Targovax ASA (Oslo) has reported tremendous safety, immunogenicity, and one-year survival data, of in the modified cohort of the TG01 trial in resected pancreatic cancer patients. more ➔
Sanofi invests €170m to expand flu jab f...Sanofi is investing €170m to expand its vaccine manufacturing site in Val de Reuil, France, which produces 900 million vaccine doses worldwide each year. more ➔
Researchers describe alternative psoriasis...British researchers have identified interleukin 36 (IL-36) as a druggable proinflammatory driver of psoriasis. Because of its very targeted effects of antibodies directed against the cytokine they want … more ➔
Neurim tables Phase III data of insomnia d...German-Israeli Neurim Pharmaceuticals announced top line efficacy results of its insomnia drug PedPRM in children with autism spectrum disorders (ASD). more ➔
Erytech Pharma set to raise US$100m in IPO...French cancer drug encapsulation specialist Erytech Pharma SA wants to raise US$100m (€85m) in an IPO at NASDAQ and a subsequent private placement outside Northern America to finance pivotal trials … more ➔
uniQure’s AMT-130 receives FDA Orpha... As first gene therapy ever, AMT-130 has been granted FDA Orphan Drug status in Huntington’s Disease. more ➔
Promethera Biosciences partners with Shibu... Promethera Biosciences and Shibuya collaborate to establish a breakthrough cell therapy manufacturing platform. more ➔
Immatics raises $58m Cancer immunotherapy specialist Immatics Biotechnologies GmbH (Tuebingen, Germany) raised US$58m in a Series E financing round led by German investors dievini Hopp BioTech Holding and AT Impf as well … more ➔
NuCana raises US$114m in IPO of ADSsScotch cancer corp NuCana plc was up 3% (to US$18.61) after closing an initial public offering on Friday led by Citigroup, Jefferies and Cowen and co-managed by William Blair. more ➔
Researchers unravel patterns of cancer het...Up to recently, it was not possible for academic researchers to visualise the spatial distribution of intratumoural heterogeneity within solid tumours. An international research team has now reported … more ➔
